Review of Short Phrases and Links|
This Review contains major "Follow-Up"- related terms, short phrases and links grouped together in the form of Encyclopedia article.
- Follow-up was for 3 weeks after discharge from hospital or for a maximum of 60 days from randomisation.
- Follow-up is recommended every 3 to 5 years for patients with a small PDA without evidence of left-heart volume overload.
- Follow-up (mean 4.56 years, range 1-12 years) was completed in 25 patients; all these patients were alive and disease-free.
- Follow-up is needed in cases of hepatitis B and C via blood tests, because symptoms are not a reliable sign regarding the presence of chronic infection.
- Follow-up was completed in all 100 patients, with a median follow-up of 24 months.
- Long-term follow-up evaluation of these patients is needed to detect early lymphoma relapse or progression," the authors conclude.
- Follow-up studies have shown that response is durable in the majority of patients and the progression of liver lesion is stopped.
- Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence.
- Long-term follow-up after the first episode of acute alcoholic pancreatitis: time course and risk factors for recurrence.
- Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.
- Follow-up care after treatment for colorectal cancer is very important.
- Blood tests can measure HCG levels; these tests are important in diagnosis, staging, and in follow-up of some testicular cancers.
- The treatment of arrhythmias has improved in recent years, so it's important you seek appropriate follow-up care.
- Arrangements will be made for a follow-up visit with your physician, usually two to three weeks after the procedure.
- A physician can adjust the intensity, duration and frequency of the stimulation, which may be minimally noticeable by the patient, in follow-up visits.
- Any nodule not removed needs to be watched closely with an examination and follow-up with the physician every 6-12 months.
- Follow-up after completion of treatment was monthly with physical examination and CA125, with radiological investigations as indicated by these findings.
- The American Society of Clinical Oncology (ASCO) sets guidelines for follow-up testing to detect recurring cancer after the completion of treatment.
- Patients returned for follow-up visits 3, 6, 9, and 12 months after completion of the medication.
- Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection.
- Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin.
- Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood.
- Follow-up documented cancer or adenoma in 83% of subjects when the polyp or mass seen during sigmoidoscopy was a centimeter or larger.
- HPV infections in 3 subjects with multiple subsequent infections during long-term follow-up: HPV DNA testing and typing along the time scale.
- Among subjects on whom follow-up data could be obtained, the median lag time between observations at T1 and T2 was 8.8 yr, and between T2 and T3 was 6.4 yr.
- DESIGN: Follow-up of up to 2 years in patients with healed ulcers who had participated in randomized, controlled trials.
- This was a randomized, controlled, single-blind trial with 3 months of follow-up in a primary care, inner-city health center.
- Fifty-five patients were randomized and 38 completed at least 1 year of follow-up.
- Concomitant medication will be documented at screening and baseline, visit 11 at the end of the treatment period as well as at each follow-up visit.
- Patients were considered lost to follow-up if they had not been seen at a visit within one year before the end of the study.
- Follow-up averaged 4.1 years; 82% of those assigned to hormone treatment were taking it at the end of 1 year, and 75% at the end of 3 years.
- At the end of the treatment period, patients are followed for a 2-week period of follow-up.
- Follow-up care for a pituitary gland tumor may include tests to measure hormone levels and MRI scans to learn how the tumor responded to treatment.
- Results: The tumor was treated by surgical excision, with no additional treatment, other than follow-up.
- At a median follow-up of 3 years, 10 of 93 patients had died, all but 1 from a second (solid) tumor.
- During your follow-up visit, your doctor will discuss the results of your biopsy with you and take out your stitches.
- A follow-up liver biopsy was performed 0.5–5.5 years (mean ± SD, 1.9 ± 1.4 years) after end of treatment in 51 patients.
- Follow-up scans for three patients showed close correlation of 67Ga uptake with myocarditis on biopsy.
- Duration of treatment and follow-up was 18 months.
- Duration of endoscopic follow-up was 6 years and follow-up based on serum levels of pepsinogen I and antibodies to H. pylori covered a period of 10 years.
- Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.
- Those with elevated cTnT levels (defined by the 99th percentile cut-off value) had an increased risk of death after 1, 2 and 3 years of follow-up.
- Participants free of hepatocellular carcinoma at their death or at the end of follow-up were censored.
- After an average follow-up period of 5.4 years, the risk of death from all causes in patients older than 65 who received simvastatin was reduced by 34%.
- Liver cancer was diagnosed post mortem in 5 patients during a follow-up study of deaths among the 215 patients who had dropped out.
- Four patients died during follow-up; 2 of these deaths were related to multiple endocrine neoplasia.
- The last follow-up of this cohort found that only 37 mesothelioma deaths had been identified among 8,000 deaths from all causes (McDonald et al., 1993).
- Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
- Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial.
- Nevertheless, the event rate in the trial was low (60% of that originally predicted), requiring the authors to extend follow-up from 5.0 to 9.5 years.
- Patients rated nasal disease-specific symptoms and completed a self-administered quality of well-being questionnaire before intervention and at follow-up.
- Despite these dietary changes, there was no evidence that the intervention reduced the risk of invasive colorectal cancer during the follow-up period.
- Clinical examination was performed at selection (visit 0, V0), inclusion (V1), follow-up (V2, week 4) and end of intervention (V3, week 8).
- Long-term follow-up studies of patients with suspected viral myocarditis reveal progression to dilated cardiomyopathy (DCM) in a significant number of cases.
- In addition, it recommends that in cases where antibiotics are not prescribed in these patients, close follow-up must be ensured.
- Patients treated on an out-of-hospital basis had no serious complications after a mean follow-up of 38 months (no cases of cardiac tamponade).
- They can be used to stage cancer, to indicate a prognosis, to monitor treatment, or in follow-up to watch for cancer recurrence.
- METHODOLOGY: All 110 patients were treated for their esophageal varices and their prognosis and complications were analyzed during the follow-up period.
- In the Rai staging system, with long-term follow-up, it appears that stage IV patients have a slightly better prognosis than Rai stage III patients.
- In trials that compared inpatient and outpatient treatment, the rates of recurrent DVT, major bleeding, and death during follow-up differed only slightly.
- The study outcome was the composite of recurrent venous thromboembolism and major bleeding during an average follow-up of 1.4 years.
- At the long-term follow-up of successful eradication cases, 89.8% of the patients were free of peptic ulcer disease.
- Results: During a mean follow-up period of 95 months, 8 patients died, 9 underwent reoperation, and 12 received catheter intervention.
- During a mean follow-up period of 24 months, 18 patients died of cardiopulmonary causes.
- Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome.
- The mean follow-up period after initial diagnosis was 22 months (range, 6 months–6 years).
- Microsoft Train Simulator 2, the follow-up to the number one best-selling train simulation PC game, will be available in stores around Christmas time.
- Taking into account a dropout rate of 25% between randomisation and end of follow-up, this would require 128 patients in each study group.
- The Apollo program was originally conceived early in 1960, during the Eisenhower administration, as a follow-up to America's Mercury program.
- Long-term follow-up after hospital discharge was incomplete with 10 patients missing in the treatment and 7 patients in the control group.
- The mean follow-up period was 2.7 years in the lamivudine group and 5.3 years in the control group.
- Male circumcision was offered to the intervention group immediately after randomization and to the control group at the end of the follow-up.
- In five patients with a follow-up between 56 months and 101 months, the last MC amplification was sequenced and compared with the original lymphoma sample.
- Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients.
- All five patients are currently alive without evidence of tumor recurrence after a median follow-up of 43 months.
- Excessive doses of thyroid hormones frequently go undetected due to the lack of follow-up of patients taking their thyroid medicine.
- After treatment for a pituitary gland tumor ends, talk with your doctor about developing a follow-up care plan.
- Once you have finished with your examination, you may resume normal activity; you need to follow-up with your doctor a few days after the examination.
- You should follow-up with your doctor as recommended and regularly examine your skin once a month, using a mirror to check hard-to-see places.
- Results During 18 years of follow-up, there were 801 incident cases of diverticulitis and 383 incident cases of diverticular bleeding.
- During 18 years of follow-up, there were 801 new cases of diverticulitis and 383 new cases of diverticular bleeding.
- During 18 years of follow-up, researchers identified 383 cases of diverticular bleeding and 801 cases of diverticulitis.
- To our knowledge, there are no reports about incidences of HCC that selected only patients who seroconverted to anti-HBe during follow-up.
- During the long-term follow-up, 4 patients with cirrhosis developed hepatocellular carcinoma (HCC), which was discovered by ultrasound examination.
- Liver nodules were found in 43 patients, 11 of whom had HCC. Cumulative incidence of HCC during follow-up was 4%.
- Our report highlights the need for careful follow-up for more than 10 years even if the patients with CH-C achieve SVR to IFN therapy.
- After 6 months of follow-up 5 patients on mono and 10 patients on combo maintained a sustained virological response (SVR: 9.8% vs 19.6%, p=ns).
- During the follow-up period, reappearance of serum HCV RNA was found in one patient, who has achieved SVR in 6-MU group, at the 57th month.
- Five years after treatment, 108 patients (81% of the initial group) were available for the follow-up of the clinical course of peptic ulcer.
- Clinical course and long-term follow-up in patients without clinically overt heart disease.
- Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up.
- All patients had radiologic investigations at follow-up to exclude disease recurrence.
- Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence.
- This can help reduce the risk of disease recurrence and facilitate follow-up monitoring.
- Eleven patients (three in the trandolapril group and eight in the placebo group) received study medication but did not return for a follow-up visit.
- This was contrary to protocol and biased the study against EDTA. Wide variability made follow-up testing of the placebo group almost totally unreliable.
- Follow-up endoscopy revealed similar rates of ulcer healing in the treatment and placebo group (84.7% and 92.8%, respectively; p=0.14).
- Six patients did not consistently wear their patches on each day in this 3-day period, and 1 patient did not return for follow-up at week 4.
- None of the six patients with IA who underwent pacemaker implantation had recurrence of asystolic events during mean follow-up of 5 years.
- Five of the six patients are still in clinical remission after a median follow-up period of 5 months.
- Follow-up care to assess the results of treatment and to check for recurrence is very important.
- Trials of the prevention of recurrence were included only if patients who had had gout and had at least 6 months of follow-up were studied.
- Surgery followed by chemotherapy for patients at high risk of recurrence, with lifelong follow-up.
- Results. Seventeen (25%) patients had recurrences of acute alcoholic pancreatitis during the follow-up.
- A benign biologic behavior has been suggested based on the absence of recurrences with a median follow-up of 3 years.
- Mean follow-up time has been 18 months, and to date no recurrences at the site of resection or port-site metastases have been observed.
- Each implant was categorized as "survival" or "failure" after 1 to 4 years of follow-up after prosthesis implantation.
- Patients had a median follow-up of 39 months and 79% of the patients were followed at least 12 months for survival and selected adverse events.
- Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome.
- The primary end point was a sustained virologic response (defined as a serum HCV RNA level below 50 IU per milliliter at the end of follow-up, at week 72).
- During follow-up, 22% of the patients (n=40) reached the primary end point.
- The primary end point was the average Izbicki pain score during 2 years of follow-up.
- During follow-up (median 24 months, range 18 to 24 months), there was no recurrence of symptoms (bleeding, tenesmus).
- The remaining two patients have also showed progressive improvement in their symptoms following surgery for 4 years on follow-up.
- Endoscopy was carried out at the end of the follow-up or whenever symptoms appeared.
- The mean duration of follow-up was 3.2 years.
- RESULTS: The mean duration of follow-up was 40 months.
- After treatment for oropharyngeal cancer, frequent and careful follow-up is important because of the risk of developing a second cancer in the head or neck.
- Laparoscopic cholecystectomy is recommended as definitive treatment for patients whose risk for general anesthesia improves in follow-up.
- This fact could facilitate the identification of patients at risk and improved care during follow-up of these patients.
- RESULTS: Average follow-up of the 3640 enrolled study participants, aged 55-80 years, was 6.3 years, with 2.4% lost to follow-up.
- The patients subsequently underwent periodic colonoscopy during an average follow-up of 5.9 years, and the incidence of colorectal cancer was ascertained.
- At an average follow-up of 27.8 months, 80 of the patients were disease free.
- It may be done as a follow-up test after treatment for an abnormal Pap test.
- Colonoscopy also is used as a follow-up test if anything unusual is found during one of the other screening tests.
- Also covers high-risk patients every two years and those needing a follow-up test after FOBT or Flex Sig.
- Humans > Health > Diseases > Patients
- Encyclopedia of Keywords > Time > Calendars > Months
- Health > Diseases > Treatments > Treatment
- Encyclopedia of Keywords > Time > Years
* Follow-Up Appointment
* Follow-Up Appointments
* Follow-Up Colonoscopy
* Follow-Up Data
* Follow-Up Evaluation
* Follow-Up Study
* Follow-Up Testing
* Follow-Up Treatment
* Follow-Up Visits
* Hepatocellular Carcinoma
* Mean Follow-Up
* Median Duration
* Median Follow-Up
* Three Patients
* Years Follow-Up
Books about "Follow-Up" in